Full Coverage

Lawmakers question Vytorin cancer risk data

reuters.co.uk
21-Aug-2008
        
Story Timeline:  105 days

WASHINGTON (Reuters) - Two top Democratic lawmakers on Thursday questioned recent claims by Merck & Co Inc and Schering Plough Corp that incidents of cancer in patients taking their cholesterol drug Vytorin were a fluke. The lawmakers, Rep. John Dingell and Rep. Bart Stupak, both from Michigan, are seeking 10 years of related company records after a study last month found Vytorin patients had a higher rate of cancer than those taking a placebo. (Reporting by Susan Heavey; editing by John... [read full story]                    

Add Comment
Latest article on this story:

FDA investigates possible Vytorin link to cancer

 physorg.com 23-Aug-2008
First article on this story:

Lawmakers demand study data on Vytorin cancer risk

 thehour.com 20-Aug-2008
Selected publications with coverage of this story:
orglex.com nbcsandiego.com crainsny.com cbs3.com tampabays10.com nbc10.com startribune.com modbee.com tbo.com kwch.com iht.com go.com
RELATED
Found 4 documents:

FDA investigates possible Vytorin link to cancer

keralanext.com
22-Aug-2008
        

WASHINGTON - Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer. However, the Food and Drug Administration said...

                   

Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk

pharmiweb.co.uk
21-Aug-2008
        

By LINDA A. JOHNSON | AP Business Writer TRENTON, N.J. (AP) _ A congressional committee is demanding that the makers of controversial cholesterol drug Vytorin, Merck & Co. and Schering-Plough Corp., produce extensive data...

FDA to Review Data on Cholesterol Drug and Cancer

pharmiweb.co.uk
21-Aug-2008
        

VYTORIN, MERCK, SCHERING-PLOUGH, MRK, SGP, CANCER, FDA U.S. Food and Drug Administration officials plan to review recently publicized data that showed a higher rate of cancer in patients taking Merck and Schering-Plough's...

FDA to Review Cholesterol Drug Link to Cancer Risk

pharmiweb.co.uk
21-Aug-2008
        

FDA to Review Data on Cholesterol Drug and Cancer VYTORIN, MERCK, SCHERING-PLOUGH, MRK, SGP, CANCER, FDA U.S. Food and Drug Administration officials plan to review recently publicized data that showed a higher rate of cancer in...